Air Products and Chemicals, Inc. (NYSE:APD) last session’s volume of 0.77 million shares was lower than its average volume of 1.27 million shares. The stock, after opening at $161.26, hit $160.86 through the close by scoring -0.8%.Air Products and Chemicals, Inc. (APD) Analyst Opinion
Air Products and Chemicals, Inc. has a consensus outperform rating from 20 Wall Street analysts, and the number of shares currently sold short amount to at least 1.12% of shares outstanding. The stock spiked 4.82% last month and is up 11.85 this year. Wall Street is only getting more bullish on the stock, with 14 of analysts who cover APD having a buy-equivalent rating. Analysts have placed a $170.79 price target on Air Products and Chemicals, Inc., suggesting a 6.17% gain from recent close. It’s currently trading about -1.65% below its 52-week high.
Air Products and Chemicals, Inc. (APD) surprised the stock market in its last reported earnings when it earned $1.76 a piece versus the consensus-estimated $1.68. Its revenue totaled $2.13 billion up 0.22% from the previous quarter.Air Products and Chemicals, Inc. (NYSE:APD) Intraday View
This stock (APD) is ahead of its 52-week low with 20.38%. Its last month’s stock price volatility remained 1.07% which for the week stands at 1.05%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.56% and stays 4.5% away from its 50 days moving average. Over the last five days, shares have faced -0.05% losses and now is up 10.83% since hitting its 200-day moving average of $148.11. Air Products and Chemicals, Inc. (APD) has made its way to a 12-month gain of 16.45%.
Turning to Selecta Biosciences, Inc. (NASDAQ:SELB), its shares were trading at $9.18 a retreat of $-0.06, on the trading floor. The stock, after opening at $9.44, touched a high of $9.4671 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Selecta Biosciences, Inc. has 2 buy ratings, 1 holds and 0 sells even after the stock tumbled -67.21% from its high of $28.00 to a $203.34 million market value through last close.
The company’s consensus rating on Reuter’s scale improved from 1.25 to 1.75 during a month. Analysts set a 12-month price target of $24 a share. The target implies a 161.44% spike from where the shares are currently trading. Also, the current price highlights a discount of 226.8% to analysts’ high consensus price target.Selecta Biosciences, Inc. (NASDAQ:SELB) Intraday Trading
The counter witnessed a trading volume of 0.31 million shares versus an average volume of 0.18 million shares during last trading session. Its last month’s stock price volatility remained 8.41% which for the week approaches 11.38%. The lowest price the stock reached in the last trading day was $9.15 and compares with the $8.70 52-week low. The stock recovered 5.52% since its low point and has performed -46.47% year-to-date.